CLINICAL_TRIALS
trial_result
· 2024-01-23
Clinical Trial Update: TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy [Phase 2]
Summary
Phase 2 clinical trial update for TXA127 in non-ambulant Duchenne muscular dystrophy–associated cardiomyopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Constant Therapeutics LLC | Conditions: DMD-Associated Dilated Cardiomyopathy | Phase 2 | Status: UNKNOWN